Najla Al-Ali

Moffitt Cancer Center

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Rami S. Komrokji

Moffitt Cancer Center

Eric Padron

Moffitt Cancer Center

David A. Sallman

Moffitt Cancer Center

Alan F. List

Precision BioSciences (United States)

Jeffrey E. Lancet

Moffitt Cancer Center

Mikkael A. Sekeres

Sylvester Comprehensive Cancer Center

Jaroslaw P. Maciejewski

Cleveland Clinic

Kendra Sweet

Moffitt Cancer Center

Amy E. DeZern

Sidney Kimmel Comprehensive Cancer Center

Guillermo García-Manero

The University of Texas MD Anderson Cancer Center

Cooperative Institutions

Moffitt Cancer Center

University of South Florida

The University of Texas MD Anderson Cancer Center

Cleveland Clinic

Cornell University

Mayo Clinic in Florida

Istituti di Ricovero e Cura a Carattere Scientifico

WinnMed

Sylvester Comprehensive Cancer Center

Mayo Clinic

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Risk Prediction for Clonal Cytopenia: Multicenter Real-World Evidence

Blood (2024)

Zhuoer Xie Rami S. Komrokji Najla Al-Ali Alexandra Regelson Susan Geyer

Cytopenia

Cumulative incidence

10.1182/blood.2024024756

Cite

Citations (8)

Improved Responses with Azacitidine Compared to Decitabine in Patients with Acute Myeloid Leukemia in Patients ≥70 with Poor-Risk Cytogenetics

Clinical Lymphoma Myeloma & Leukemia (2017)

Chetasi Talati Andrew Kuykendall Najla Al-Ali Rami S. Komrokji Eric Padron

Decitabine

Azacitidine

Hypomethylating agent

10.1016/j.clml.2017.07.085

Cite

Citations (5)

Epigenetic Profiling in High-Risk MDS and AML Patients Identifies Pre-Treatment Methylation Patterns That Indicate Response to Hypomethylating Agents: A Pilot Study

Blood (2016)

Chetasi Talati Adam G. Marsh Kylie Baggett Najla Al-Ali Kendra Sweet

Azacitidine

Decitabine

Hypomethylating agent

CpG site

10.1182/blood.v128.22.2885.2885

Cite

Citations (0)

Characterization of Myelodysplastic Syndromes (MDS) with T-Cell Large Granular Lymphocyte Proliferations (LGL)

Blood (2016)

Christa Roe Najla Al-Ali Eric Padron Pearlie K. Burnette Kendra Sweet

clone (Java method)

Immunophenotyping

Azacitidine

Bone marrow failure

10.1182/blood.v128.22.113.113

Cite

Citations (2)

Myelodysplastic/Myeloproliferative Neoplasms Unclassified (MDS/MPN-U) Overlap: Can We Alter the Natural History?

Blood (2016)

Kaitlin Hendrix Najla Al-Ali Eric Padron David A. Sallman Alan F. List

Decitabine

Myeloproliferative neoplasm

Log-rank test

10.1182/blood.v128.22.3125.3125

Cite

Citations (4)

Outcome of azacitidine treatment in patients with therapy-related myeloid neoplasms with assessment of prognostic risk stratification models

Leukemia Research (2013)

Vu H. Duong Jeffrey E. Lancet Ezzideen Alrawi Najla Al-Ali Janelle Perkins

Azacitidine

Risk Stratification

10.1016/j.leukres.2012.12.012

Cite

Citations (20)

Optimal Treatment Order of Lenalidomide and Hypomethylating Agents for Lower-Risk Myelodysplastic Syndromes: A Report on Behalf of the MDS Clinical Research Consortium

Blood (2016)

Rami S. Komrokji Mikkael A. Sekeres John Barnard Najla Al-Ali Amy E. DeZern

Decitabine

Hypomethylating agent

Azacitidine

10.1182/blood.v128.22.4322.4322

Cite

Citations (3)

Second Myeloid Malignancies in a Large Cohort of Patients With Chronic Lymphocytic Leukemia: A Single Institution Experience

Clinical Lymphoma Myeloma & Leukemia (2015)

Julio C. Chávez Samir Dalia Jose Sandoval‐Sus Mohamed A. Kharfan‐Dabaja Najla Al-Ali

10.1016/j.clml.2015.03.013

Cite

Citations (7)

Defining Acute Myeloid Leukemia Ontogeny in Older Patients

Clinical Lymphoma Myeloma & Leukemia (2017)

Megan Melody David A. Sallman Najla Al-Ali Hanadi Ramadan Ling Zhang

10.1016/j.clml.2017.07.052

Cite

Citations (0)

Monocytosis in myelofibrosis is associated with clinical outcome, hematologic abnormalities and somatic mutations

Clinical Lymphoma Myeloma & Leukemia (2017)

Daniel Kerr Andrew Kuykendall Chetasi Talati Najla Al-Ali David A. Sallman

Monocytosis

Myeloproliferative neoplasm

10.1016/j.clml.2017.07.188

Cite

Citations (0)